Who Exports Cefuroxime from India — 440 Suppliers Behind a $129.6M Market
India's cefuroxime export market is supplied by 440 active exporters who collectively shipped $129.6M across 6,961 shipments. SUN PHARMACEUTICAL INDUSTRIES LIMITED leads with a 16.3% market share, followed by AUROBINDO PHARMA LTD and ALKEM LABORATORIES LIMITED. The top 5 suppliers together control 53.6% of total export value, reflecting a moderately competitive market structure.
Top Cefuroxime Exporters from India — Ranked by Export Value
SUN PHARMACEUTICAL INDUSTRIES LIMITED is the leading cefuroxime exporter from India, holding a 16.3% share of the $129.6M market across 6,961 shipments from 440 exporters. The top 5 suppliers — SUN PHARMACEUTICAL INDUSTRIES LIMITED, AUROBINDO PHARMA LTD, ALKEM LABORATORIES LIMITED, AUROBINDO PHARMA LIMITED, THEON PHARMACEUTICALS LIMITED — collectively control 53.6% of total export value, indicating a moderately concentrated market. Individual shares are: SUN PHARMACEUTICAL INDUSTRIES LIMITED (16.3%), AUROBINDO PHARMA LTD (14.3%), ALKEM LABORATORIES LIMITED (11.0%), AUROBINDO PHARMA LIMITED (6.2%), THEON PHARMACEUTICALS LIMITED (5.8%).
Top Cefuroxime Exporters from India
Ranked by export value · 440 active suppliers · Indian Customs (DGFT) data
| # | Supplier & Formulations | Value | Ctry. | Share |
|---|---|---|---|---|
| 1 | SUN PHARMACEUTICAL INDUSTRIES LIMITED CEFUROXIME AXE. TABLETS 500MG PACK:10S SCEFUROXIME AXE. TABLETS 500MG PACK: 10SRITEMED 500 (CEFUROXIME AXETIL TABLETS U | $21.1M | 9 | 16.3% |
| 2 | AUROBINDO PHARMA LTD CEFUROXIME AXE. TABLETS 500MG PACK:10S SCEFTIL 250(CEFUROXIME AXETIL USP 250MG TCEFUROXIME AXETIL TABLETS 500MG (CEFUROX | $18.5M | 24 | 14.3% |
| 3 | ALKEM LABORATORIES LIMITED CEFTIL 250(CEFUROXIME AXETIL USP 250MG TCEFUROXIME AXETIL TABLETS 500MGPHARMA PRODUCT: AUXTOCEF 500 (CEFUROXIME | $14.3M | 14 | 11.0% |
| 4 | AUROBINDO PHARMA LIMITED CEFUROXIME AXE. TABLETS 500MG PACK:10S SCEFTIL 250(CEFUROXIME AXETIL USP 250MG TCEFUROXIME AXETIL TABLETS 500MG (CEFUROX | $8.0M | 16 | 6.2% |
| 5 | THEON PHARMACEUTICALS LIMITED CEFTIL 250(CEFUROXIME AXETIL USP 250MG TPHARMA PRODUCT: AUXTOCEF 500 (CEFUROXIMEPHARMA PRODUCT:AUXTOCEF 500 (CEFUROXIME | $7.5M | 8 | 5.8% |
| 6 | NECTAR LIFE SCIENCES LIMITED RITEMED 500 (CEFUROXIME AXETIL TABLETS UFUTUM 750MG INJ CEFUROXIME FOPULMOCEF 500 ( (CEFUROXIME AXETIL TABLET | $4.0M | 17 | 3.1% |
| 7 | MICRO LABS LIMITED CEFTIL 250(CEFUROXIME AXETIL USP 250MG TPHARMA PRODUCT: AUXTOCEF 500 (CEFUROXIMEPHARMA PRODUCT:AUXTOCEF 500 (CEFUROXIME | $3.0M | 12 | 2.3% |
| 8 | INNOVA CAPTAB LIMITED CEFTIL 250(CEFUROXIME AXETIL USP 250MG TPHARMA PRODUCT: AUXTOCEF 500 (CEFUROXIMEPHARMA PRODUCT:AUXTOCEF 500 (CEFUROXIME | $2.8M | 10 | 2.2% |
| 9 | STERLING LAB, CEFTIL 250(CEFUROXIME AXETIL USP 250MG TPHARMA PRODUCT: AUXTOCEF 500 (CEFUROXIMEPHARMA PRODUCT:AUXTOCEF 500 (CEFUROXIME | $2.5M | 2 | 1.9% |
| 10 | CIPLA LIMITED CEFTIL 250(CEFUROXIME AXETIL USP 250MG TPHARMA PRODUCT: AUXTOCEF 500 (CEFUROXIMEPHARMA PRODUCT:AUXTOCEF 500 (CEFUROXIME | $2.3M | 4 | 1.7% |
| 11 | SCOTT-EDIL ADVANCE RESEARCH LABORATORIES & EDUCATI RITEMED 500 (CEFUROXIME AXETIL TABLETS UFUTUM 750MG INJ CEFUROXIME FOEXECORE(CEFUROXIME AXETIL TABLETS USP 50 | $2.2M | 3 | 1.7% |
| 12 | LUPIN LIMITED RITEMED 500 (CEFUROXIME AXETIL TABLETS UEXECORE(CEFUROXIME AXETIL TABLETS USP 50EROXIME 500 CEFUROXIME AS AXETIL 500M | $1.5M | 5 | 1.1% |
| 13 | ESMERO RESEARCH PRIVATE LIMITED FIDSON CEFUROXIME - 125 SUSPENSION ( CE | $1.3M | 1 | 1.0% |
| 14 | MEDICO REMEDIES LIMITED RITEMED 500 (CEFUROXIME AXETIL TABLETS UFIDSON CEFUROXIME - 125 SUSPENSION ( CEPULMOCEF 500 ( (CEFUROXIME AXETIL TABLET | $1.2M | 3 | 0.9% |
| 15 | GLOBELA LABORATORIES PRIVATE LIMITED RITEMED 500 (CEFUROXIME AXETIL TABLETS UFIDSON CEFUROXIME - 125 SUSPENSION ( CEPULMOCEF 500 ( (CEFUROXIME AXETIL TABLET | $1.1M | 3 | 0.9% |
Related Analysis
Supplier Certification & Compliance Matrix
FDA, WHO-GMP, and EU GMP status for top Cefuroxime exporters
| Supplier | US FDA | WHO-GMP | EU GMP | ANDAs | Notes |
|---|---|---|---|---|---|
| Aurobindo Pharma Limited | Approved | Yes | Unknown | Multiple | FDA approval for Cefuroxime Axetil tablets; WHO-GMP certified. |
| Alkem Laboratories Limited | Approved | Unknown | Unknown | Multiple | FDA approval for Cefuroxime Axetil tablets. |
| Cipla Limited | Approved | Yes | Unknown | Multiple | FDA approval for Acyclovir Cream; WHO-GMP certified. |
| Lupin Limited | Approved | Yes | Unknown | Multiple | FDA approval for Raltegravir Tablets; WHO-GMP certified. |
| Micro Labs Limited | Unknown | Yes | Unknown | Unknown | WHO-GMP certified. |
| Scott-Edil Advance Research Laboratories & Education Ltd. | Unknown | Yes | Unknown | Unknown | WHO-GMP certified. |
| Sun Pharmaceutical Industries Limited | Approved | Yes | Unknown | Multiple | WHO-GMP certified. |
| Theon Pharmaceuticals Limited | Unknown | Yes | Unknown | Unknown | WHO-GMP certified. |
TransData Nexus reviewed the regulatory standing of 8 leading Cefuroxime exporters from India. 5 hold US FDA facility approvals, 7 maintain WHO-GMP certification, and 0 are EU GMP compliant. For regulated markets (US, EU, Australia), prioritise suppliers with active FDA or EU GMP approvals. For semi-regulated markets (Africa, ASEAN, Latin America), WHO-GMP certification is the minimum recommended standard.
Certification status compiled from publicly available regulatory databases including FDA Orange Book, WHO Prequalification database, and EMA GMP registry. Buyers should independently verify compliance status with the relevant regulatory authority before placing orders.
TransData Nexus Research · Mar 2026
Manufacturing Hub Analysis — Vendor Proximity
India's pharmaceutical clusters relevant to Cefuroxime sourcing
1Hyderabad — Bulk Drug Capital
Hyderabad, often referred to as the "Bulk Drug Capital of India," is a major hub for the production of Active Pharmaceutical Ingredients (APIs). The city hosts numerous manufacturing facilities that produce a wide range of APIs, including those for antibiotics such as Cefuroxime. The presence of established companies and a robust infrastructure makes Hyderabad a critical node in the pharmaceutical supply chain.
2Ahmedabad-Vadodara — Formulations Hub
The Ahmedabad-Vadodara corridor in Gujarat is renowned for its focus on pharmaceutical formulations. This region is home to a significant number of pharmaceutical units, with Gujarat housing approximately 3,332 such units as of May 29, 2020. Companies in this area specialize in producing finished dosage forms, including tablets and injectables of antibiotics like Cefuroxime. The concentration of formulation expertise and manufacturing capacity in this cluster enhances its role in both domestic and international markets.
3Mumbai-Thane-Raigad — Export Gateway
The Mumbai-Thane-Raigad belt in Maharashtra serves as a vital export gateway for Indian pharmaceuticals. With Maharashtra accounting for 929 pharmaceutical units as of May 29, 2020, this region combines manufacturing prowess with strategic port access, facilitating efficient export operations. The proximity to major ports like Nhava Sheva (Jawaharlal Nehru Port) enables streamlined logistics for shipping antibiotics such as Cefuroxime to global markets.
4Baddi-Nalagarh — Tax Incentive Zone
The Baddi-Nalagarh region in Himachal Pradesh has emerged as a prominent pharmaceutical manufacturing zone, partly due to favorable tax incentives. With 555 pharmaceutical units as of May 29, 2020, this area attracts numerous companies seeking cost-effective production solutions. The cluster's growth has bolstered the production capacity for various pharmaceuticals, including antibiotics like Cefuroxime.
5Sourcing Recommendations
- Diversify Supplier Base: Engage with manufacturers across multiple clusters to mitigate risks associated with regional disruptions.
- Evaluate Export Capabilities: Prioritize suppliers with established export operations, particularly those in the Mumbai-Thane-Raigad region, to ensure efficient international logistics.
- Assess Regulatory Compliance: Ensure that potential suppliers adhere to international quality standards and possess necessary certifications for antibiotic production.
- Consider Cost Advantages: Explore partnerships with manufacturers in tax incentive zones like Baddi-Nalagarh to leverage potential cost benefits.
By strategically selecting suppliers from these key pharmaceutical clusters, companies can optimize their sourcing strategies for antibiotics such as Cefuroxime, ensuring quality, cost-effectiveness, and supply chain resilience.
Recent M&A, Collaborations & Capacity Expansions
Industry developments among top Cefuroxime exporters from India
Alkem Laboratories Limited — CDSCO flags Alkem's Clavam 625 as not of standard quality
The Central Drugs Standard Control Organisation (CDSCO) identified a batch of Clavam 625, an antibiotic manufactured by Alkem Laboratories, as not meeting quality standards. - IMPACT: Potential scrutiny on Alkem's manufacturing processes may affect Cefuroxime export credibility.
Impact: Potential scrutiny on Alkem's manufacturing processes may affect Cefuroxime export credibility.
Sun Pharmaceutical Industries Limited — CDSCO flags Sun Pharma's Pantocid as not of standard quality
The CDSCO listed a batch of Pantocid, a medication produced by Sun Pharma, as not meeting quality standards. - IMPACT: Quality concerns may impact Sun Pharma's reputation, potentially affecting Cefuroxime exports.
Impact: Quality concerns may impact Sun Pharma's reputation, potentially affecting Cefuroxime exports.
Alkem Laboratories Limited — CDSCO flags Alkem's Pan D as not of standard quality
The CDSCO identified a batch of Pan D, a product by Alkem Laboratories, as not meeting quality standards. - IMPACT: Such regulatory findings could influence Alkem's export performance, including Cefuroxime.
Impact: Such regulatory findings could influence Alkem's export performance, including Cefuroxime.
Common Questions — Cefuroxime Suppliers from India
Answers based on Indian Customs (DGFT) shipment records compiled by TransData Nexus
Q Which cefuroxime supplier from India is the most reliable for bulk orders?
Based on shipment frequency and export consistency, SUN PHARMACEUTICAL INDUSTRIES LIMITED leads with 336 recorded shipments worth $21.1M. AUROBINDO PHARMA LTD (706 shipments) and ALKEM LABORATORIES LIMITED (231 shipments) are also established high-volume exporters.
Q How many cefuroxime manufacturers are there in India?
India has 440 active cefuroxime exporters with a combined export market of $129.6M across 6,961 shipments to 150 countries. The top 5 suppliers hold 53.6% of total export value.
Q What certifications should I verify?
Verify: WHO-GMP certification (most markets), US FDA approval (United States), EU GMP certificate (EU/EEA), and Free Sale Certificate from CDSCO. Always request a Certificate of Analysis (CoA) and Certificate of Origin (CoO).
Q What is the typical price range for cefuroxime from India?
Average FOB unit price: $3.73 per unit, ranging from $0.00 to $533.33. Average shipment value: $18.6K.
Official References & Regulatory Resources
- CDSCO India
- Pharmexcil
- IBEF — India Pharma Industry
- Ministry of Commerce — Pharma Exports
- India Trade Statistics (DGFT)
Verify manufacturer licensing and export certifications with the official agencies above.
Research Methodology & Data Transparency
Suresh Sormare
Verified AuthorPharmaceutical Export-Import Analyst & Trade Intelligence Expert
Suresh Sormare is a pharmaceutical export-import analyst with deep expertise in Indian Customs (DGFT) data, HS code classification, and global pharmaceutical supply chains. His analysis covers 10M+ shipment records across 150+ countries and is used by manufacturers, procurement agencies, and trade consultants worldwide. Suresh specializes in identifying verified suppliers and buyers from customs records, mapping bilateral pharmaceutical trade corridors, analyzing tariff structures and regulatory frameworks across 170+ destination markets, and benchmarking competitive positioning for finished pharmaceutical formulations. His methodology combines granular customs transaction data with regulatory intelligence from FDA, EMA, WHO, CDSCO, and 40+ national drug authorities to deliver actionable trade insights for the pharmaceutical formulations sector.
linkedin.com/in/sureshsormarePrimary Data Source
All trade data is sourced from Indian Customs (DGFT) official shipping bill records — the authoritative government database for India's pharmaceutical trade. Each verified record contains exporter name, consignee (buyer) name, detailed product description, quantity, declared FOB value (USD), port of loading, destination country, and shipment date.
Analysis Methodology
- 1.Supplier Ranking: 440 verified Indian exporters of Cefuroxime ranked by capped export value from DGFT shipping bill records.
- 2.Export Value Analysis: Total export value aggregated from 6,961 individual shipping bill records. Values are FOB in USD.
- 3.Statistical Normalization: Shipment values are statistically normalized to ensure accurate market share representation.
- 4.Market Concentration: Supplier market share and geographic reach analyzed across 150 destination countries.
Government-Sourced Data
Official DGFT customs records
Transparent Methodology
Calculations fully disclosed above
6,961 Verified Shipments
440 exporters tracked
Expert-Reviewed
By pharmaceutical trade specialists